Last update:

Coronavirus (COVID-19)

Medications

Oral nucleoside antiviral is progressing toward future pandemic preparedness

Obeldesivir (GS-5245), a novel investigational small molecule oral antiviral, represents a new tool in the ongoing effort to prepare for future pandemics.

Medical research

Study reports new compound that halts replication of COVID by targeting 'Mac-1' protein in cell models

Research appearing in the Journal of Medicinal Chemistry shows for the first time SARS-CoV-2, the virus responsible for COVID-19, can be inhibited from replicating in living cell cultures using a compound that targets "Mac-1," ...

COVID-19 outbreak

Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization Country Office in China on 31 December 2019 and recognised as a pandemic on 11 March 2020.

Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases.

More information: WHO, CDC, global cases.

Follow us on Google News for the latest updates on the coronavirus.

Immunology

How COVID-19 'breakthrough' infections alter your immune cells

New research from scientists at La Jolla Institute for Immunology (LJI) suggests people who received COVID-19 vaccines and then experienced "breakthrough" infections are especially well armed against future SARS-CoV-2 infections.

Diseases, Conditions, Syndromes

Study confirms effectiveness of bivalent COVID-19 vaccine

A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to ...

Diseases, Conditions, Syndromes

Long-term smell, but not taste, deficits seen after COVID-19

Olfactory dysfunction, especially for smell, is more common in individuals with prior COVID-19 versus individuals with no history of infection, with deficits varying by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...

Medications

Study finds metformin reduces COVID-19 viral load, viral rebound

A team of University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, can decrease the amount of COVID-19 virus in the body and lower the chances of the virus coming back strongly after ...

Vaccination

AstraZeneca withdraws Covid vaccine as demand dives

Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing COVID vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons" following a slump in demand.